Laetsch, T. W., DuBois, S. G., Mascarenhas, L., Turpin, B., Federman, N., Albert, C. M., . . . Hawkins, D. S. (2018). Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: Phase 1 results from a multicentre, open-label, phase 1/2 study. The lancet oncology, 19(5), 705-714. https://doi.org/10.1016/S1470-2045(18)30119-0
Citace podle Chicago (17th ed.)Laetsch, Theodore W., et al. "Larotrectinib for Paediatric Solid Tumours Harbouring NTRK Gene Fusions: Phase 1 Results from a Multicentre, Open-label, Phase 1/2 Study." The Lancet Oncology 19, no. 5 (2018): 705-714. https://doi.org/10.1016/S1470-2045(18)30119-0.
Citace podle MLA (9th ed.)Laetsch, Theodore W., et al. "Larotrectinib for Paediatric Solid Tumours Harbouring NTRK Gene Fusions: Phase 1 Results from a Multicentre, Open-label, Phase 1/2 Study." The Lancet Oncology, vol. 19, no. 5, 2018, pp. 705-714, https://doi.org/10.1016/S1470-2045(18)30119-0.